1 min read

Why Privacy Changes Demand a Better Approach to Targeting: Real World Data

Featured Image

By: Emilie Branch, Content Manager, Swoop 

Building custom audience segments can help marketers better reach consumers.

Katie Carr, SVP of sales at Swoop, explains how pharma brands can leverage condition-specific patient segments to connect with more relevant consumer audiences online. Carr delves into the privacy changes being made by branded technology walled gardens and why strengthening targeting via a custom-built patient audience segment puts advertisers in a more favorable position as those shifts occur.

 


About the Author

Emilie Branch 

Content Manager

  Emilie_Headshot_cropped2 (1)

 

Emilie has nearly a decade of experience in marketing, writing, research and strategy for the pharmaceutical industry. She has contributed to top pharmaceutical publications including American Pharmaceutical Review, European Pharmaceutical Review, Pharmaceutical Manufacturing, Manufacturing Chemist, Pharmaceutical Outsourcing, Specialty Chemicals, and Contract Pharma. Prior to joining Swoop/IPM.ai, Emilie served as Strategic Content Manager and Managing Editor for Pharma’s Almanac where she lent her voice to some of the industry’s top players including GSK, MilliporeSigma and ThermoFisher Scientific. 

 

Implementing Conversational AI Lifts Patient and Prescriber High-Value Activity by 825% and 400% for a Top Ten Pharma’s Neurological Drug

The Challenge 

Facing a massive growth of interest in their leading neurological treatment, a top ten pharmaceutical company sought to digitally...

Read More

Transforming How Pharma Marketers Find, Target and Engage with Patients and Providers

As healthcare marketing experiences pivotal changes, from increased privacy restrictions to differing consumer behavior, working with a reliable data...

Read More